Provectus Biopharmaceuticals, Inc. Stock
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
OTC Markets
05:37:28 03/06/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.0620 USD | -7.32% |
|
+8.58% | +10.91% |
| Market Cap | 22.27M 19.9M 18.57M 16.87M 31.77M 2.15B 32M 223M 87.17M 1.1B 83.62M 81.82M 3.52B | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 25M 22.34M 20.84M 18.93M 35.65M 2.42B 35.92M 250M 97.85M 1.23B 93.86M 91.83M 3.95B | EV / Sales 2024 |
86,451,912x | EV / Sales 2025 | 78,013,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| 1 day | -7.32% | ||
| 1 week | +8.58% | ||
| Current month | +8.58% | ||
| 1 month | +3.33% | ||
| 3 months | -9.88% | ||
| 6 months | +24.75% | ||
| Current year | +10.91% |
| 1 week | 0.05 |  | 0.07 |
| 1 month | 0.05 | | 0.07 |
| Current year | 0.04 | | 0.08 |
| 1 year | 0.04 | | 0.08 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 16/04/2024 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/05/2012 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 25/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 03/04/2017 | |
John Lacey
BRD | Director/Board Member | 78 | 27/04/2018 |
Edward Pershing
CHM | Chairman | 73 | 27/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/10/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 18/9/26 | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 11/9/26 | Exercice | Chief Executive Officer | -13,216 | 0.1400% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.32% | +8.58% | -26.93% | -25.39% | 22.27M | |
| +4.16% | +4.16% | +49.37% | +94.17% | 74.69B | |
| +0.46% | -0.97% | +23.51% | +79.57% | 58.81B | |
| +0.17% | +0.35% | +6.85% | +34.55% | 48.45B | |
| -0.01% | -2.30% | +330.62% | +687.36% | 42.84B | |
| -0.52% | -3.69% | +28.91% | +29.77% | 42.79B | |
| +0.48% | -0.48% | +6.60% | +110.76% | 41.25B | |
| -0.11% | +1.96% | +9.19% | +52.66% | 31.13B | |
| -2.07% | +1.16% | +35.00% | +26.28% | 30.28B | |
| +0.89% | -1.73% | -8.92% | -11.63% | 24.05B | |
| Average | -0.42% | -0.23% | +45.42% | +107.81% | 39.43B | |
| Weighted average by Cap. | +0.72% | -0.54% | +56.32% | +128.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.55 0.51 0.47 0.88 59.7 0.89 6.18 2.42 30.36 2.32 2.27 97.6 | 0.34 0.3 0.28 0.25 0.48 32.51 0.48 3.37 1.32 16.54 1.26 1.23 53.16 |
| Net income | -4.76M -4.25M -3.97M -3.61M -6.79M -461M -6.84M -47.7M -18.64M -234M -17.88M -17.49M -753M | -5.43M -4.85M -4.53M -4.11M -7.74M -525M -7.8M -54.4M -21.25M -267M -20.39M -19.95M -859M |
| Net Debt | 2.88M 2.57M 2.4M 2.18M 4.1M 278M 4.13M 28.82M 11.26M 142M 10.8M 10.57M 455M | 2.73M 2.44M 2.27M 2.07M 3.89M 264M 3.92M 27.32M 10.67M 134M 10.24M 10.02M 431M |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/10/26 | USD 0.0530 | -0.28% | 33,645 |
| 05/10/26 | USD 0.0532 | -2.30% | 10,732 |
| 02/10/26 | USD 0.0544 | -.--% | 15,072 |
| 01/10/26 | USD 0.0544 | -4.73% | 425,782 |
| 30/09/26 | USD 0.0571 | -.--% | 5,300 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
